Daratumumab, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
Clinical trial NCT03841565 · WITHDRAWN
Trial details
- NCT number
- NCT03841565
- Sponsor
- Academic and Community Cancer Research United
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-07
- Primary completion
- 2022-02-09
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.